SERETIDE vs FLIXOTIDE in Mild Persistent Asthma (GINAII)
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms GINAII
- Sponsors GlaxoSmithKline
- 27 Nov 2008 Actual end date changed from Mar 2006 to Jul 2007 as reported by ClinicalTrials.gov.
- 28 Feb 2008 Status changed from in progress to completed.
- 16 Apr 2007 New trial record.